Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Nuclear Medicine-Radiopharmaceuticals Market Professional Survey Report 2016

  • QYR737900
  • 111 Pages
  • November 2016
  • Medical Devices
Download Sample    Get Discount   
 
Notes:

Production, means the output of Nuclear Medicine-Radiopharmaceuticals

Revenue, means the sales value of Nuclear Medicine-Radiopharmaceuticals

This report studies Nuclear Medicine-Radiopharmaceuticals in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Cardinal Health, Inc (US)

GE Healthcare (UK)

Bracco Imaging S.p.A (Italy)

Nordion, Inc. (Canada)

Bayer HealthCare Medical Care (US)

Lantheus Medical Imaging Inc (US)

Advanced Medical Isotope Corporation (US)

Alliance Medical (UK)

Alseres Pharmaceuticals, Inc (US)

Avid Radiopharmaceuticals (US)

Actinium Pharmaceuticals Inc (US)

Ion Beam Applications S.A (Belgium)

Immunomedics, Inc. (US)

Jubilant Pharma (India)

Mallinckrodt Pharmaceuticals (Ireland)

Medi-Radiopharma Ltd (Hungary)

Peregrine Pharmaceuticals, Inc. (US)

Siemens Healthcare (US)

Positron Corporation (US)

Triad Isotopes, Inc. (US)

By types, the market can be split into

Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.

Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

Type III

By Application, the market can be split into

Diagnostic Applications: SPECT, PET.

Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

Application 3

By Regions, this report covers (we can add the regions/countries as you want)

North America

China

Europe

Southeast Asia

Japan

India

Table of Contents

Global Nuclear Medicine-Radiopharmaceuticals Market Professional Survey Report 2016

1 Industry Overview of Nuclear Medicine-Radiopharmaceuticals

1.1 Definition and Specifications of Nuclear Medicine-Radiopharmaceuticals

1.1.1 Definition of Nuclear Medicine-Radiopharmaceuticals

1.1.2 Specifications of Nuclear Medicine-Radiopharmaceuticals

1.2 Classification of Nuclear Medicine-Radiopharmaceuticals

1.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.

1.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

1.2.3 Type III

1.3 Applications of Nuclear Medicine-Radiopharmaceuticals

1.3.1 Diagnostic Applications: SPECT, PET.

1.3.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

1.3.3 Application 3

1.4 Market Segment by Regions

1.4.1 North America

1.4.2 China

1.4.3 Europe

1.4.4 Southeast Asia

1.4.5 Japan

1.4.6 India

2 Manufacturing Cost Structure Analysis of Nuclear Medicine-Radiopharmaceuticals

2.1 Raw Material and Suppliers

2.2 Manufacturing Cost Structure Analysis of Nuclear Medicine-Radiopharmaceuticals

2.3 Manufacturing Process Analysis of Nuclear Medicine-Radiopharmaceuticals

2.4 Industry Chain Structure of Nuclear Medicine-Radiopharmaceuticals

3 Technical Data and Manufacturing Plants Analysis of Nuclear Medicine-Radiopharmaceuticals

3.1 Capacity and Commercial Production Date of Global Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015

3.2 Manufacturing Plants Distribution of Global Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015

3.3 R&D Status and Technology Source of Global Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015

3.4 Raw Materials Sources Analysis of Global Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015

4 Global Nuclear Medicine-Radiopharmaceuticals Overall Market Overview

4.1 2011-2016E Overall Market Analysis

4.2 Capacity Analysis

4.2.1 2011-2016E Global Nuclear Medicine-Radiopharmaceuticals Capacity and Growth Rate Analysis

4.2.2 2015 Nuclear Medicine-Radiopharmaceuticals Capacity Analysis (Company Segment)

4.3 Sales Analysis

4.3.1 2011-2016E Global Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate Analysis

4.3.2 2015 Nuclear Medicine-Radiopharmaceuticals Sales Analysis (Company Segment)

4.4 Sales Price Analysis

4.4.1 2011-2016E Global Nuclear Medicine-Radiopharmaceuticals Sales Price

4.4.2 2015 Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis (Company Segment)

5 Nuclear Medicine-Radiopharmaceuticals Regional Market Analysis

5.1 North America Nuclear Medicine-Radiopharmaceuticals Market Analysis

5.1.1 North America Nuclear Medicine-Radiopharmaceuticals Market Overview

5.1.2 North America 2011-2016E Nuclear Medicine-Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis

5.1.3 North America 2011-2016E Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis

5.1.4 North America 2015 Nuclear Medicine-Radiopharmaceuticals Market Share Analysis

5.2 China Nuclear Medicine-Radiopharmaceuticals Market Analysis

5.2.1 China Nuclear Medicine-Radiopharmaceuticals Market Overview

5.2.2 China 2011-2016E Nuclear Medicine-Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis

5.2.3 China 2011-2016E Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis

5.2.4 China 2015 Nuclear Medicine-Radiopharmaceuticals Market Share Analysis

5.3 Europe Nuclear Medicine-Radiopharmaceuticals Market Analysis

5.3.1 Europe Nuclear Medicine-Radiopharmaceuticals Market Overview

5.3.2 Europe 2011-2016E Nuclear Medicine-Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis

5.3.3 Europe 2011-2016E Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis

5.3.4 Europe 2015 Nuclear Medicine-Radiopharmaceuticals Market Share Analysis

5.4 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Market Analysis

5.4.1 Southeast Asia Nuclear Medicine-Radiopharmaceuticals Market Overview

5.4.2 Southeast Asia 2011-2016E Nuclear Medicine-Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis

5.4.3 Southeast Asia 2011-2016E Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis

5.4.4 Southeast Asia 2015 Nuclear Medicine-Radiopharmaceuticals Market Share Analysis

5.5 Japan Nuclear Medicine-Radiopharmaceuticals Market Analysis

5.5.1 Japan Nuclear Medicine-Radiopharmaceuticals Market Overview

5.5.2 Japan 2011-2016E Nuclear Medicine-Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis

5.5.3 Japan 2011-2016E Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis

5.5.4 Japan 2015 Nuclear Medicine-Radiopharmaceuticals Market Share Analysis

5.6 India Nuclear Medicine-Radiopharmaceuticals Market Analysis

5.6.1 India Nuclear Medicine-Radiopharmaceuticals Market Overview

5.6.2 India 2011-2016E Nuclear Medicine-Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis

5.6.3 India 2011-2016E Nuclear Medicine-Radiopharmaceuticals Sales Price Analysis

5.6.4 India 2015 Nuclear Medicine-Radiopharmaceuticals Market Share Analysis

6 Global 2011-2016E Nuclear Medicine-Radiopharmaceuticals Segment Market Analysis (by Type)

6.1 Global 2011-2016E Nuclear Medicine-Radiopharmaceuticals Sales by Type

6.2 Different Types of Nuclear Medicine-Radiopharmaceuticals Product Interview Price Analysis

6.3 Different Types of Nuclear Medicine-Radiopharmaceuticals Product Driving Factors Analysis

6.3.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. of Nuclear Medicine-Radiopharmaceuticals Growth Driving Factor Analysis

6.3.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes of Nuclear Medicine-Radiopharmaceuticals Growth Driving Factor Analysis

6.3.3 Type III Nuclear Medicine-Radiopharmaceuticals Growth Driving Factor Analysis

7 Global 2011-2016E Nuclear Medicine-Radiopharmaceuticals Segment Market Analysis (by Application)

7.1 Global 2011-2016E Nuclear Medicine-Radiopharmaceuticals Consumption by Application

7.2 Different Application of Nuclear Medicine-Radiopharmaceuticals Product Interview Price Analysis

7.3 Different Application of Nuclear Medicine-Radiopharmaceuticals Product Driving Factors Analysis

7.3.1 Diagnostic Applications: SPECT, PET. of Nuclear Medicine-Radiopharmaceuticals Growth Driving Factor Analysis

7.3.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. of Nuclear Medicine-Radiopharmaceuticals Growth Driving Factor Analysis

7.3.3 Application 3 Nuclear Medicine-Radiopharmaceuticals Growth Driving Factor Analysis

8 Major Manufacturers Analysis of Nuclear Medicine-Radiopharmaceuticals

8.1 Cardinal Health, Inc (US)

8.1.1 Company Profile

8.1.2 Product Picture and Specifications

8.1.2.1 Type I

8.1.2.2 Type II

8.1.2.3 Type III

8.1.3 Cardinal Health, Inc (US) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.1.4 Cardinal Health, Inc (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.2 GE Healthcare (UK)

8.2.1 Company Profile

8.2.2 Product Picture and Specifications

8.2.2.1 Type I

8.2.2.2 Type II

8.2.2.3 Type III

8.2.3 GE Healthcare (UK) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.2.4 GE Healthcare (UK) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.3 Bracco Imaging S.p.A (Italy)

8.3.1 Company Profile

8.3.2 Product Picture and Specifications

8.3.2.1 Type I

8.3.2.2 Type II

8.3.2.3 Type III

8.3.3 Bracco Imaging S.p.A (Italy) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.3.4 Bracco Imaging S.p.A (Italy) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.4 Nordion, Inc. (Canada)

8.4.1 Company Profile

8.4.2 Product Picture and Specifications

8.4.2.1 Type I

8.4.2.2 Type II

8.4.2.3 Type III

8.4.3 Nordion, Inc. (Canada) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.4.4 Nordion, Inc. (Canada) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.5 Bayer HealthCare Medical Care (US)

8.5.1 Company Profile

8.5.2 Product Picture and Specifications

8.5.2.1 Type I

8.5.2.2 Type II

8.5.2.3 Type III

8.5.3 Bayer HealthCare Medical Care (US) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.5.4 Bayer HealthCare Medical Care (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.6 Lantheus Medical Imaging Inc (US)

8.6.1 Company Profile

8.6.2 Product Picture and Specifications

8.6.2.1 Type I

8.6.2.2 Type II

8.6.2.3 Type III

8.6.3 Lantheus Medical Imaging Inc (US) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.6.4 Lantheus Medical Imaging Inc (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.7 Advanced Medical Isotope Corporation (US)

8.7.1 Company Profile

8.7.2 Product Picture and Specifications

8.7.2.1 Type I

8.7.2.2 Type II

8.7.2.3 Type III

8.7.3 Advanced Medical Isotope Corporation (US) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.7.4 Advanced Medical Isotope Corporation (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.8 Alliance Medical (UK)

8.8.1 Company Profile

8.8.2 Product Picture and Specifications

8.8.2.1 Type I

8.8.2.2 Type II

8.8.2.3 Type III

8.8.3 Alliance Medical (UK) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.8.4 Alliance Medical (UK) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.9 Alseres Pharmaceuticals, Inc (US)

8.9.1 Company Profile

8.9.2 Product Picture and Specifications

8.9.2.1 Type I

8.9.2.2 Type II

8.9.2.3 Type III

8.9.3 Alseres Pharmaceuticals, Inc (US) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.9.4 Alseres Pharmaceuticals, Inc (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.10 Avid Radiopharmaceuticals (US)

8.10.1 Company Profile

8.10.2 Product Picture and Specifications

8.10.2.1 Type I

8.10.2.2 Type II

8.10.2.3 Type III

8.10.3 Avid Radiopharmaceuticals (US) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.10.4 Avid Radiopharmaceuticals (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.11 Actinium Pharmaceuticals Inc (US)

8.11.1 Company Profile

8.11.2 Product Picture and Specifications

8.11.2.1 Type I

8.11.2.2 Type II

8.11.2.3 Type III

8.11.3 Actinium Pharmaceuticals Inc (US) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.11.4 Actinium Pharmaceuticals Inc (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.12 Ion Beam Applications S.A (Belgium)

8.12.1 Company Profile

8.12.2 Product Picture and Specifications

8.12.2.1 Type I

8.12.2.2 Type II

8.12.2.3 Type III

8.12.3 Ion Beam Applications S.A (Belgium) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.12.4 Ion Beam Applications S.A (Belgium) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.13 Immunomedics, Inc. (US)

8.13.1 Company Profile

8.13.2 Product Picture and Specifications

8.13.2.1 Type I

8.13.2.2 Type II

8.13.2.3 Type III

8.13.3 Immunomedics, Inc. (US) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.13.4 Immunomedics, Inc. (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.14 Jubilant Pharma (India)

8.14.1 Company Profile

8.14.2 Product Picture and Specifications

8.14.2.1 Type I

8.14.2.2 Type II

8.14.2.3 Type III

8.14.3 Jubilant Pharma (India) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.14.4 Jubilant Pharma (India) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.15 Mallinckrodt Pharmaceuticals (Ireland)

8.15.1 Company Profile

8.15.2 Product Picture and Specifications

8.15.2.1 Type I

8.15.2.2 Type II

8.15.2.3 Type III

8.15.3 Mallinckrodt Pharmaceuticals (Ireland) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.15.4 Mallinckrodt Pharmaceuticals (Ireland) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.16 Medi-Radiopharma Ltd (Hungary)

8.16.1 Company Profile

8.16.2 Product Picture and Specifications

8.16.2.1 Type I

8.16.2.2 Type II

8.16.2.3 Type III

8.16.3 Medi-Radiopharma Ltd (Hungary) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.16.4 Medi-Radiopharma Ltd (Hungary) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.17 Peregrine Pharmaceuticals, Inc. (US)

8.17.1 Company Profile

8.17.2 Product Picture and Specifications

8.17.2.1 Type I

8.17.2.2 Type II

8.17.2.3 Type III

8.17.3 Peregrine Pharmaceuticals, Inc. (US) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.17.4 Peregrine Pharmaceuticals, Inc. (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.18 Siemens Healthcare (US)

8.18.1 Company Profile

8.18.2 Product Picture and Specifications

8.18.2.1 Type I

8.18.2.2 Type II

8.18.2.3 Type III

8.18.3 Siemens Healthcare (US) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.18.4 Siemens Healthcare (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.19 Positron Corporation (US)

8.19.1 Company Profile

8.19.2 Product Picture and Specifications

8.19.2.1 Type I

8.19.2.2 Type II

8.19.2.3 Type III

8.19.3 Positron Corporation (US) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.19.4 Positron Corporation (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

8.20 Triad Isotopes, Inc. (US)

8.20.1 Company Profile

8.20.2 Product Picture and Specifications

8.20.2.1 Type I

8.20.2.2 Type II

8.20.2.3 Type III

8.20.3 Triad Isotopes, Inc. (US) 2015 Nuclear Medicine-Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis

8.20.4 Triad Isotopes, Inc. (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution Analysis

9 Development Trend of Analysis of Nuclear Medicine-Radiopharmaceuticals Market

9.1 Global Nuclear Medicine-Radiopharmaceuticals Market Trend Analysis

9.1.1 Global 2016-2021 Nuclear Medicine-Radiopharmaceuticals Market Size (Volume and Value) Forecast

9.1.2 Global 2016-2021 Nuclear Medicine-Radiopharmaceuticals Sales Price Forecast

9.2 Nuclear Medicine-Radiopharmaceuticals Regional Market Trend

9.2.1 North America 2016-2021 Nuclear Medicine-Radiopharmaceuticals Consumption Forecast

9.2.2 China 2016-2021 Nuclear Medicine-Radiopharmaceuticals Consumption Forecast

9.2.3 Europe 2016-2021 Nuclear Medicine-Radiopharmaceuticals Consumption Forecast

9.2.4 Southeast Asia 2016-2021 Nuclear Medicine-Radiopharmaceuticals Consumption Forecast

9.2.5 Japan 2016-2021 Nuclear Medicine-Radiopharmaceuticals Consumption Forecast

9.2.6 India 2016-2021 Nuclear Medicine-Radiopharmaceuticals Consumption Forecast

9.3 Nuclear Medicine-Radiopharmaceuticals Market Trend (Product Type)

9.4 Nuclear Medicine-Radiopharmaceuticals Market Trend (Application)

10 Nuclear Medicine-Radiopharmaceuticals Marketing Type Analysis

10.1 Nuclear Medicine-Radiopharmaceuticals Regional Marketing Type Analysis

10.2 Nuclear Medicine-Radiopharmaceuticals International Trade Type Analysis

10.3 Traders or Distributors with Contact Information of Nuclear Medicine-Radiopharmaceuticals by Regions

10.4 Nuclear Medicine-Radiopharmaceuticals Supply Chain Analysis

11 Consumers Analysis of Nuclear Medicine-Radiopharmaceuticals

11.1 Consumer 1 Analysis

11.2 Consumer 2 Analysis

11.3 Consumer 3 Analysis

11.4 Consumer 4 Analysis

12 Conclusion of the Global Nuclear Medicine-Radiopharmaceuticals Market Professional Survey Report 2016

Author List

Table Part of Interviewees Record List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

List of Tables and Figures

Figure Picture of Nuclear Medicine-Radiopharmaceuticals

Table Product Specifications of Nuclear Medicine-Radiopharmaceuticals

Table Classification of Nuclear Medicine-Radiopharmaceuticals

Figure Global Production Market Share of Nuclear Medicine-Radiopharmaceuticals by Type in 2015

Figure Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals. Picture

Table Major Manufacturers of Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals.

Figure Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes Picture

Table Major Manufacturers of Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

Table Applications of Nuclear Medicine-Radiopharmaceuticals

Figure Global Consumption Volume Market Share of Nuclear Medicine-Radiopharmaceuticals by Application in 2015

Figure Diagnostic Applications: SPECT, PET. Examples

Table Major Consumers of Diagnostic Applications: SPECT, PET.

Figure Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. Examples

Table Major Consumers of Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

Figure Market Share of Nuclear Medicine-Radiopharmaceuticals by Regions

Figure North America Nuclear Medicine-Radiopharmaceuticals Market Size (2011-2021)

Figure China Nuclear Medicine-Radiopharmaceuticals Market Size (2011-2021)

Figure Europe Nuclear Medicine-Radiopharmaceuticals Market Size (2011-2021)

Figure Southeast Asia Nuclear Medicine-Radiopharmaceuticals Market Size (2011-2021)

Figure Japan Nuclear Medicine-Radiopharmaceuticals Market Size (2011-2021)

Figure India Nuclear Medicine-Radiopharmaceuticals Market Size (2011-2021)

Table Nuclear Medicine-Radiopharmaceuticals Raw Material and Suppliers

Table Manufacturing Cost Structure Analysis of Nuclear Medicine-Radiopharmaceuticals in 2015

Figure Manufacturing Process Analysis of Nuclear Medicine-Radiopharmaceuticals

Figure Industry Chain Structure of Nuclear Medicine-Radiopharmaceuticals

Table Capacity (K Ton) and Commercial Production Date of Global Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015

Table Manufacturing Plants Distribution of Global Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015

Table R&D Status and Technology Source of Global Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015

Table Raw Materials Sources Analysis of Global Nuclear Medicine-Radiopharmaceuticals Major Manufacturers in 2015

Table Global Capacity (K Ton) , Sales (K Ton) , Price (USD/Ton) , Cost (USD/Ton) , Sales Revenue (M USD) and Gross Margin of Nuclear Medicine-Radiopharmaceuticals 2011-2016

Figure Global 2011-2016E Nuclear Medicine-Radiopharmaceuticals Market Size (Volume) and Growth Rate

Figure Global 2011-2016E Nuclear Medicine-Radiopharmaceuticals Market Size (Value) and Growth Rate

Table 2011-2016E Global Nuclear Medicine-Radiopharmaceuticals Capacity and Growth Rate

Table 2015 Global Nuclear Medicine-Radiopharmaceuticals Capacity List (Company Segment)

Table 2011-2016E Global Nuclear Medicine-Radiopharmaceuticals Sales and Growth Rate

Table 2015 Global Nuclear Medicine-Radiopharmaceuticals Sales List (Company Segment)

Table 2011-2016E Global Nuclear Medicine-Radiopharmaceuticals Sales Price

Table 2015 Global Nuclear Medicine-Radiopharmaceuticals Sales Price List (Company Segment)

Figure North America Capacity Overview

Table North America Supply, Import, Export and Consumption of Nuclear Medicine-Radiopharmaceuticals 2011-2016 (K Ton)

Figure North America 2011-2016E Nuclear Medicine-Radiopharmaceuticals Sales Price (USD/Ton)

Figure North America 2015 Nuclear Medicine-Radiopharmaceuticals Sales Market Share

Figure China Capacity Overview

Table China Supply, Import, Export and Consumption of Nuclear Medicine-Radiopharmaceuticals 2011-2016 (K Ton)

Figure China 2011-2016E Nuclear Medicine-Radiopharmaceuticals Sales Price (USD/Ton)

Figure China 2015 Nuclear Medicine-Radiopharmaceuticals Sales Market Share

Figure Europe Capacity Overview

Table Europe Supply, Import, Export and Consumption of Nuclear Medicine-Radiopharmaceuticals 2011-2016 (K Ton)

Figure Europe 2011-2016E Nuclear Medicine-Radiopharmaceuticals Sales Price (USD/Ton)

Figure Europe 2015 Nuclear Medicine-Radiopharmaceuticals Sales Market Share

Figure Southeast Asia Capacity Overview

Table Southeast Asia Supply, Import, Export and Consumption of Nuclear Medicine-Radiopharmaceuticals 2011-2016 (K Ton)

Figure Southeast Asia 2011-2016E Nuclear Medicine-Radiopharmaceuticals Sales Price (USD/Ton)

Figure Southeast Asia 2015 Nuclear Medicine-Radiopharmaceuticals Sales Market Share

Figure Japan Capacity Overview

Table Japan Supply, Import, Export and Consumption of Nuclear Medicine-Radiopharmaceuticals 2011-2016 (K Ton)

Figure Japan 2011-2016E Nuclear Medicine-Radiopharmaceuticals Sales Price (USD/Ton)

Figure Japan 2015 Nuclear Medicine-Radiopharmaceuticals Sales Market Share

Figure India Capacity Overview

Table India Supply, Import, Export and Consumption of Nuclear Medicine-Radiopharmaceuticals 2011-2016 (K Ton)

Figure India 2011-2016E Nuclear Medicine-Radiopharmaceuticals Sales Price (USD/Ton)

Figure India 2015 Nuclear Medicine-Radiopharmaceuticals Sales Market Share

Table Global 2011-2016E Nuclear Medicine-Radiopharmaceuticals Sales by Type

Table Different Types Nuclear Medicine-Radiopharmaceuticals Product Interview Price

Table Global 2011-2016E Nuclear Medicine-Radiopharmaceuticals Sales by Application

Table Different Application Nuclear Medicine-Radiopharmaceuticals Product Interview Price

Table Cardinal Health, Inc (US) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Cardinal Health, Inc (US) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Cardinal Health, Inc (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table GE Healthcare (UK) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 GE Healthcare (UK) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 GE Healthcare (UK) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Bracco Imaging S.p.A (Italy) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Bracco Imaging S.p.A (Italy) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Bracco Imaging S.p.A (Italy) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Nordion, Inc. (Canada) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Nordion, Inc. (Canada) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Nordion, Inc. (Canada) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Bayer HealthCare Medical Care (US) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Bayer HealthCare Medical Care (US) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Bayer HealthCare Medical Care (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Lantheus Medical Imaging Inc (US) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Lantheus Medical Imaging Inc (US) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Lantheus Medical Imaging Inc (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Advanced Medical Isotope Corporation (US) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Advanced Medical Isotope Corporation (US) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Advanced Medical Isotope Corporation (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Alliance Medical (UK) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Alliance Medical (UK) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Alliance Medical (UK) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Alseres Pharmaceuticals, Inc (US) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Alseres Pharmaceuticals, Inc (US) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Alseres Pharmaceuticals, Inc (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Avid Radiopharmaceuticals (US) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Avid Radiopharmaceuticals (US) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Avid Radiopharmaceuticals (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Actinium Pharmaceuticals Inc (US) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Actinium Pharmaceuticals Inc (US) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Actinium Pharmaceuticals Inc (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Ion Beam Applications S.A (Belgium) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Ion Beam Applications S.A (Belgium) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Ion Beam Applications S.A (Belgium) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Immunomedics, Inc. (US) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Immunomedics, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Immunomedics, Inc. (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Jubilant Pharma (India) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Jubilant Pharma (India) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Jubilant Pharma (India) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Mallinckrodt Pharmaceuticals (Ireland) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Mallinckrodt Pharmaceuticals (Ireland) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Mallinckrodt Pharmaceuticals (Ireland) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Medi-Radiopharma Ltd (Hungary) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Medi-Radiopharma Ltd (Hungary) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Medi-Radiopharma Ltd (Hungary) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Peregrine Pharmaceuticals, Inc. (US) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Peregrine Pharmaceuticals, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Peregrine Pharmaceuticals, Inc. (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Siemens Healthcare (US) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Siemens Healthcare (US) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Siemens Healthcare (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Positron Corporation (US) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Positron Corporation (US) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Positron Corporation (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Table Triad Isotopes, Inc. (US) Information List

Table Type I Nuclear Medicine-Radiopharmaceuticals Overview

Table Type II Nuclear Medicine-Radiopharmaceuticals Overview

Table Type III Nuclear Medicine-Radiopharmaceuticals Overview

Table 2015 Triad Isotopes, Inc. (US) Nuclear Medicine-Radiopharmaceuticals Revenue, Sales, Ex-factory Price

Figure 2015 Triad Isotopes, Inc. (US) 2015 Nuclear Medicine-Radiopharmaceuticals Business Region Distribution

Figure Global 2016-2021 Nuclear Medicine-Radiopharmaceuticals Market Size (Volume) and Growth Rate Forecast

Figure Global 2016-2021 Nuclear Medicine-Radiopharmaceuticals Market Size (Value) and Growth Rate Forecast

Figure Global 2016-2021 Nuclear Medicine-Radiopharmaceuticals Sales Price (USD/Ton) Forecast

Figure North America 2016-2021 Nuclear Medicine-Radiopharmaceuticals Consumption Volume and Growth Rate Forecast

Figure China 2016-2021 Nuclear Medicine-Radiopharmaceuticals Consumption Volume and Growth Rate Forecast

Figure Europe 2016-2021 Nuclear Medicine-Radiopharmaceuticals Consumption Volume and Growth Rate Forecast

Figure Southeast Asia 2016-2021 Nuclear Medicine-Radiopharmaceuticals Consumption Volume and Growth Rate Forecast

Figure Japan 2016-2021 Nuclear Medicine-Radiopharmaceuticals Consumption Volume and Growth Rate Forecast

Figure India 2016-2021 Nuclear Medicine-Radiopharmaceuticals Consumption Volume and Growth Rate Forecast

Table Global Sales Volume (K Ton) of Nuclear Medicine-Radiopharmaceuticals by Types 2016-2021

Table Global Consumption Volume (K Ton) of Nuclear Medicine-Radiopharmaceuticals by Applications 2016-2021

Table Traders or Distributors with Contact Information of Nuclear Medicine-Radiopharmaceuticals by Regions

Table Part of Interviewees Record List

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370